Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 5351 - 5375 of 5959 in total
Experimental
Phenothiazine (PTZ) is an organic thiazine compound.
Experimental
Vet approved
Experimental
Sarconeos is an activator of the MAS receptor.
Investigational
Disomotide is a synthetic peptide cancer vaccine.
Investigational
Ginisortamab is under investigation in clinical trial NCT04393298 (A Study to Assess the Safety, Pharmacokinetics and Anti Tumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid Tumors).
Investigational
Arimoclomol is an experimental drug compound developed by CytRx Corporation, a biopharmaceutical company based in Los Angeles, California. The orally administered drug is intended to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, a neurodegenerative disease with no effective treatment.
Investigational
Investigational
Zoptarelin doxorubicin has been used in trials studying the treatment of Breast Cancer, Ovarian Cancer, Prostate Cancer, Endometrial Cancer, and Urothelial Carcinoma, among others.
Investigational
An estrogenic steroid produced by horses. It has a total of four double bonds in the A- and B-ring. High concentration of equilin is found in the urine of pregnant mares.
Experimental
Investigational
Displaying drugs 5351 - 5375 of 5959 in total